公开(公告)号：US20160250395A1

公开(公告)日：2016-09-01

申请号：US15028803

申请日：2014-09-10

Applicant: ONO PHARMACEUTICAL CO., LTD. ,  OSAKA UNIVERSITY

Inventor： Yoshiki Sawa ,  Toru Kuratani ,  Koichi Toda ,  Takayoshi Ueno ,  Shigeru Miyagawa ,  Satsuki Fukushima ,  Atsuhiro Saito ,  Yoshiki Watanabe ,  Yoshiki Sakai

IPC: A61L31/16 ,  A61F2/07 ,  A61L31/14 ,  A61F2/82

CPC classification number: A61L31/16 ,  A61F2/07 ,  A61F2/82 ,  A61F2240/001 ,  A61F2250/0067 ,  A61F2310/0097 ,  A61K9/0024 ,  A61K31/343 ,  A61K31/4406 ,  A61K31/5585 ,  A61K47/34 ,  A61K47/36 ,  A61K47/42 ,  A61L31/148 ,  A61L2300/412 ,  A61L2300/602

Abstract: The present invention provides a drug-eluting stent graft for preventing stent graft-related complications as well as treating aneurysm. Specifically, the present invention relates to a drug-eluting stent graft comprising a drug, a drug-retaining agent and a stent graft, and a method for therapy of aneurysm including the use of the drug-eluting stent graft.

Abstract translation: 本发明提供了用于预防支架移植物相关并发症以及治疗动脉瘤的药物洗脱支架移植物。 具体而言，本发明涉及包含药物，药物保留剂和支架移植物的药物洗脱支架移植物，以及包括使用药物洗脱支架移植物的动脉瘤治疗方法。

公开(公告)号：US09968716B2

公开(公告)日：2018-05-15

申请号：US15028803

申请日：2014-09-10

Applicant: Ono Pharmaceutical Co., Ltd. ,  Osaka University

Inventor： Yoshiki Sawa ,  Toru Kuratani ,  Koichi Toda ,  Takayoshi Ueno ,  Shigeru Miyagawa ,  Satsuki Fukushima ,  Atsuhiro Saito ,  Yoshiki Watanabe ,  Yoshiki Sakai

IPC: A61L31/16 ,  A61F2/07 ,  A61L31/14 ,  A61F2/82 ,  A61K47/34 ,  A61K47/36 ,  A61K47/42 ,  A61K31/343 ,  A61K31/4406 ,  A61K31/5585 ,  A61K9/00

CPC classification number: A61L31/16 ,  A61F2/07 ,  A61F2/82 ,  A61F2240/001 ,  A61F2250/0067 ,  A61F2310/0097 ,  A61K9/0024 ,  A61K31/343 ,  A61K31/4406 ,  A61K31/5585 ,  A61K47/34 ,  A61K47/36 ,  A61K47/42 ,  A61L31/148 ,  A61L2300/412 ,  A61L2300/602

Abstract: The present invention provides a drug-eluting stent graft for preventing stent graft-related complications as well as treating aneurysm. Specifically, the present invention relates to a drug-eluting stent graft comprising a drug, a drug-retaining agent and a stent graft, and a method for therapy of aneurysm including the use of the drug-eluting stent graft.